1/10
07:02 pm
lung
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return [Yahoo! Finance]
Low
Report
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return [Yahoo! Finance]
12/25
07:00 pm
lung
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]
Low
Report
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]
12/11
02:33 am
lung
What New Catalysts Are Shifting the Pulmonx Story for Investors [Yahoo! Finance]
Medium
Report
What New Catalysts Are Shifting the Pulmonx Story for Investors [Yahoo! Finance]
12/3
04:05 pm
lung
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
High
Report
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/16
01:10 am
lung
Medium
Report
11/13
09:01 am
lung
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
High
Report
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
11/13
06:04 am
lung
How Recent Shifts Are Rewriting the Story for Pulmonx [Yahoo! Finance]
High
Report
How Recent Shifts Are Rewriting the Story for Pulmonx [Yahoo! Finance]
11/12
07:25 pm
lung
Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline [Seeking Alpha]
High
Report
Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline [Seeking Alpha]
11/12
07:22 pm
lung
Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
04:53 pm
lung
Pulmonx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
High
Report
Pulmonx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/12
04:05 pm
lung
Pulmonx Reports Third Quarter 2025 Financial Results
High
Report
Pulmonx Reports Third Quarter 2025 Financial Results